Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$35,723,420
+$2,105,343 QoQ
Shares Held
140,660
+2.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#536
of 4,664 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Union Bancaire Privee, UBP SA holds $312,808,826 across 11 Drug Manufacturers - General names. JNJ ranks #3 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,844 | $125,753,049 | |
| 2 | ABBV |
AbbVie Inc.
|
370,591 | $93,255,519 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
140,660 | $35,723,420 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
589,334 | $33,957,425 | |
| 5 | MRK |
Merck & Co., Inc.
|
108,638 | $13,959,983 | |
| 6 | PFE |
Pfizer Inc
|
174,631 | $4,205,114 | |
| 7 | AMGN |
Amgen Inc
|
8,255 | $2,989,300 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
19,021 | $2,403,113 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,723,420 | 140,660 | Shares | Defined | 2026-07-16 | |
| 2026-03-31 | $33,618,077 | 137,531 | Shares | Defined | 2026-04-22 | |
| 2025-12-31 | $33,660,417 | 162,650 | Shares | Defined | 2026-01-05 | |
| 2025-09-30 | $29,158,778 | 157,258 | Shares | Defined | 2025-10-07 | |
| 2025-06-30 | $24,519,582 | 160,521 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $26,038,040 | 157,007 | Shares | Defined | 2025-04-16 | |
| 2024-12-31 | $87,381,862 | 604,217 | Shares | Defined | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||